IMTX
NASDAQ · Biotechnology
Immatics Nv
$9.78
+0.26 (+2.73%)
Open$9.77
Previous Close$9.52
Day High$9.98
Day Low$9.62
52W High$12.41
52W Low$5.05
Volume—
Avg Volume414.3K
Market Cap1.31B
P/E Ratio—
EPS$-1.71
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+689.9% upside
Current
$9.78
$9.78
Target
$77.25
$77.25
$52.47
$77.25 avg
$103.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 54.81M | 83.84M | 330.72M |
| Net Income | -223,060,106 | -307,104,322 | -35,950,365 |
| Profit Margin | -407.0% | -386.7% | -10.9% |
| EBITDA | -196,261,218 | -285,219,759 | -62,958,224 |
| Free Cash Flow | — | — | -53,039,983 |
| Rev Growth | -34.6% | -34.6% | -2.7% |
| Debt/Equity | 0.03 | 0.03 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |